Last analyzed: May 28, 2026 (Q1 FY26)

Royalty Pharma plc

RPRX

Pharmaceuticals

$54.48

Market Cap

$31M

P/E Ratio

28.347368

Revenue Rank

Rank 3

Margin Rank

Rank 3

Performance Parameter: Indicating Future Growth(Based on Quarterly Earnings Call)

Explore More Tools

Discover more ways to research and analyze Indian stocks